Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
A.B. Sanchez-Spitman, J.J. Swen, V.O. Dezentje, D.J.A.R. Moes, H. Gelderblom & H.J. Guchelaar. (2019) Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen. Expert Review of Clinical Pharmacology 12:6, pages 523-536.
Read now
Read now
Junjun Lu, He Li, Peng Guo, Rui Shen, Yingbin Luo, Qiao Ge, Wenfei Shi, Yan Li & Weikang Zhu. (2017) The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis. OncoTargets and Therapy 10, pages 5429-5437.
Read now
Read now
Wanaporn Charoenchokthavee, Nutthada Areepium, Duangchit Panomvana & Virote Sriuranpong. (2017) Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients. Breast Cancer: Targets and Therapy 9, pages 249-256.
Read now
Read now
Insee Sensorn, Chonlaphat Sukasem, Ekaphop Sirachainan, Montri Chamnanphon, Ekawat Pasomsub, Narumol Trachu, Porntip Supavilai, Darawan Pinthong & Sansanee Wongwaisayawan. (2016) ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen. OncoTargets and Therapy 9, pages 2121-2129.
Read now
Read now
Sadeep Medhasi, Ekawat Pasomsub, Natchaya Vanwong, Nattawat Ngamsamut, Apichaya Puangpetch, Montri Chamnanphon, Yaowaluck Hongkaew, Penkhae Limsila, Darawan Pinthong & Chonlaphat Sukasem. (2016) Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder. Neuropsychiatric Disease and Treatment 12, pages 843-851.
Read now
Read now
Wanaporn Charoenchokthavee, Duangchit Panomvana, Virote Sriuranpong & Nutthada Areepium. (2016) Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment. Breast Cancer: Targets and Therapy 8, pages 149-155.
Read now
Read now
Articles from other publishers (3)
Thomas Helland, Sarah Alsomairy, Chenchia Lin, Håvard Søiland, Gunnar Mellgren & Daniel Louis Hertz. (2021) Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer. Journal of Personalized Medicine 11:3, pages 201.
Crossref
Crossref
Amal A. El Daibani, Fatemah A. Alherz, Maryam S. Abunnaja, Ahsan F. Bairam, Mohammed I. Rasool, Katsuhisa Kurogi & Ming-Cheh Liu. (2020) Impact of Human SULT1E1 Polymorphisms on the Sulfation of 17β-Estradiol, 4-Hydroxytamoxifen, and Diethylstilbestrol by SULT1E1 Allozymes. European Journal of Drug Metabolism and Pharmacokinetics 46:1, pages 105-118.
Crossref
Crossref
Yu Bai, Hai-wei Wu & Yan-hua Zhang. (2018) Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia: a meta-analysis. Cancer Chemotherapy and Pharmacology 83:1, pages 71-79.
Crossref
Crossref